Mempel Martin, Ronet Catherine, Suarez Felipe, Gilleron Martine, Puzo Germain, Van Kaer Luc, Lehuen Agnès, Kourilsky Philippe, Gachelin Gabriel
Unité de Biologie Moléculaire du Gène, Institut National de la Santé et de la Recherche Médicale, Unité 277, Département d'Immunologie, Institut Pasteur, 25 Rue du Dr. Roux, 75015 Paris, France.
J Immunol. 2002 Jan 1;168(1):365-71. doi: 10.4049/jimmunol.168.1.365.
Murine Valpha14(inv)T cells (NKT cells), restricted by the CD1d1 MHC 1b molecules, are a distinctive subset of T cells endowed with pleiotropic functions. CD1d1-restricted NKT cells infiltrate the granulomas induced by the s.c. injection of mycobacterial phosphatidylinositoldimannoside (PIM(2)) but not of its deacylated derivative. NKT cells are detectable as early as 6 hours following the injection. Although the molecular structure of PIM(2) meets the requirements for presentation by CD1d1, Ab blocking and adoptive transfer experiments of wild-type NKT cells into CD1d1(-/-) mice show that CD1d1 expression is not required for the early recruitment of NKT cells to the injection site. This conclusion was confirmed by the finding that IL-12Rbeta(-/-) and CD40(-/-) mice were able to recruit NKT cells after PIM(2) challenge. Moreover, the injection of alpha-galactosylceramide, an NKT cell ligand that is recognized in the context of CD1d1, promoted only a minor recruitment of NKT cells. By contrast, injection of beta-galactosylceramide, a synthetic glycolipid that binds to CD1d1 but does not activate the CD1d/TCR pathway, resulted in the development of large granulomas rich in NKT cells. Finally, local injection of TNF-alpha mimics the effect of glycolipids. It is concluded that NKT cells migrate to and accumulate at inflammatory sites in the same way as other cells of the innate immune system and that migration to and accumulation at inflammatory sites are processes independent of the CD1d1 molecule.
受CD1d1 MHC 1b分子限制的小鼠Valpha14(inv)T细胞(NKT细胞)是具有多效性功能的独特T细胞亚群。CD1d1限制的NKT细胞浸润皮下注射分枝杆菌磷脂酰肌醇二甘露糖苷(PIM(2))而非其脱酰基衍生物所诱导的肉芽肿。注射后6小时即可检测到NKT细胞。尽管PIM(2)的分子结构符合由CD1d1呈递的要求,但抗体阻断实验以及将野生型NKT细胞过继转移至CD1d1(-/-)小鼠的实验表明,NKT细胞早期募集至注射部位并不需要CD1d1的表达。IL-12Rbeta(-/-)和CD40(-/-)小鼠在PIM(2)攻击后能够募集NKT细胞这一发现证实了该结论。此外,注射α-半乳糖神经酰胺(一种在CD1d1背景下被识别的NKT细胞配体)仅促进了少量NKT细胞的募集。相比之下,注射β-半乳糖神经酰胺(一种与CD1d1结合但不激活CD1d/TCR途径的合成糖脂)导致富含NKT细胞的大型肉芽肿形成。最后局部注射TNF-α模拟了糖脂的作用。得出的结论是,NKT细胞以与先天性免疫系统的其他细胞相同的方式迁移至炎症部位并在那里聚集,并且迁移至炎症部位并在那里聚集是独立于CD1d1分子的过程。